Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INCYTE CORPINCY · Entity 3182 | EVP & Chief Scientific Officer | August 05, 2026 | August 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INCYTE CORP
Report date August 05, 2026 · Filed August 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 63,648 |
Reported balance
After 2026-08-05 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-08-05 · Exercise / conversion · Acquired 2,207 · Balance 63,648 |
| Common StockSEC Table I · non-derivative | Direct | 61,441 |
Reported balance
After 2026-08-05 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-08-05 · Sale · Disposed 2,207 · Balance 61,441 F1: This includes an aggregate of 59,537 shares of common stock issuable pursuant to previously reported restricted stock units have not vested. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $106.47 · Expires 2030-07-01 | Direct | 0 |
Reported balance
After 2026-08-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-08-05 · Exercise / conversion · Disposed 2,207 · Balance 0 F2: As of August 5th, 2026, the award is fully vested and exercisable |
Filing footnotes · ownership attribution and instrument terms
F1: This includes an aggregate of 59,537 shares of common stock issuable pursuant to previously reported restricted stock units have not vested.
F2: As of August 5th, 2026, the award is fully vested and exercisable
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 15, 2026 Filed Jul 16, 2026 20:07 UTC | INCYTE CORP INCY · Entity 3182 | Tax withholdingCommon Stock | 1,512 | $115.09 | $174,016.08 |
DisclosureSEC source: 0002079962-26-000009 · wk-form4_1784232473.xml · nonDerivative · entry 2 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,712 F1 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock. F2 · balance_after: Includes an aggregate of 53,621 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Read SEC document |
| July 14, 2026 Filed Jul 16, 2026 20:07 UTC | INCYTE CORP INCY · Entity 3182 | Tax withholdingCommon Stock | 437 | $114.88 | $50,202.56 |
DisclosureSEC source: 0002079962-26-000009 · wk-form4_1784232473.xml · nonDerivative · entry 1 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,224 F1 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock. Read SEC document |
| July 02, 2026 Filed Jul 7, 2026 20:10 UTC | INCYTE CORP INCY · Entity 3182 | Tax withholdingCommon Stock | 350 | $116.86 | $40,901.00 |
DisclosureSEC source: 0002079962-26-000007 · wk-form4_1783455016.xml · nonDerivative · entry 1 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,661 F1 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock. F2 · balance_after: Includes an aggregate of 58,730 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Read SEC document |
| January 16, 2026 Filed Jan 21, 2026 21:04 UTC | INCYTE CORP INCY · Entity 3182 | GrantEmployee Stock Option (right to buy) · Derivative | 4,218 | $0.00 Strike: $106.21 | $0.00 |
DisclosureSEC source: 0002079962-26-000002 · wk-form4_1769029464.xml · derivative · entry 1 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,218 Underlying: Common Stock · 4,218 shares Expires 2036-01-15 F1 · derivative.exercise_date: Beginning January 16, 2026, options become exercisable in 37 installments, with the first 25% vesting on July 15, 2026 and the remainder vesting monthly over three years. Read SEC document |
| December 11, 2025 Filed Dec 12, 2025 21:01 UTC | INCYTE CORP INCY · Entity 3182 | SaleCommon Stock | 255 | $94.94 | $24,209.70 |
DisclosureSEC source: 0002079962-25-000004 · wk-form4_1765573311.xml · nonDerivative · entry 2 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,011 F1 · balance_after: Includes an aggregate of 59,858 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 21:01 UTC | INCYTE CORP INCY · Entity 3182 | SaleCommon Stock | 5,553 | $95.58 | $530,755.74 |
DisclosureSEC source: 0002079962-25-000004 · wk-form4_1765573311.xml · nonDerivative · entry 1 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,266 Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 20:02 UTC | INCYTE CORP INCY · Entity 3182 | Tax withholdingCommon Stock | 1,569 | $86.70 | $136,032.30 |
DisclosureSEC source: 0002079962-25-000002 · wk-form4_1759521772.xml · nonDerivative · entry 1 Mayes Patrick A · CIK 0002079962 · EVP & Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,819 F1 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock. F2 · balance_after: Includes an aggregate of 59,858 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.